Odyssey Therapeutics, Inc. (ODTX)
NASDAQ: ODTX · Real-Time Price · USD
18.13
+0.33 (1.85%)
At close: Jun 26, 2026, 4:00 PM EDT
18.06
-0.07 (-0.39%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Odyssey Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Odyssey Therapeutics stock have an average target of 32, with a low estimate of 26 and a high estimate of 40. The average target predicts an increase of 76.50% from the current stock price of 18.13.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Odyssey Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 |
|---|---|
| Strong Buy | 4 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 18, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $40 | Buy | Reiterates | $40 | +120.63% | Jun 18, 2026 |
| Wedbush | Wedbush | Buy Maintains $30 | Buy | Maintains | $30 | +65.47% | Jun 16, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 2, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $26 | Buy | Initiates | $26 | +43.41% | Jun 2, 2026 |
Financial Forecast
Revenue This Year
n/a
from 2.98M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-4.55
EPS Next Year
-3.88
from -4.55
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | - | |
| Avg | -100.0% | - | |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.55 | -2.90 | |
| Avg | -4.55 | -3.88 | |
| Low | -4.55 | -4.55 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.